Article ; Online: Exploration of New Therapies for Heart Failure Targeting Age-Related Mechanisms.
Circulation journal : official journal of the Japanese Circulation Society
2023 Volume 88, Issue 5, Page(s) 626–630
Abstract: Evidence indicates a role of cellular senescence and systemic insulin resistance (hyperinsulinemia) in the pathogenesis of age-related cardiovascular-metabolic disorders, including heart failure, atherosclerotic diseases, obesity, and diabetes. " ... ...
Abstract | Evidence indicates a role of cellular senescence and systemic insulin resistance (hyperinsulinemia) in the pathogenesis of age-related cardiovascular-metabolic disorders, including heart failure, atherosclerotic diseases, obesity, and diabetes. "Metabolic remodeling" is one of the keywords for aging research, and studies with brown adipose tissue have shown that maintaining the homeostasis of this organ is crucial to suppressing the progression of pathologies in obesity and heart failure. The mechanisms contributing to the synchronization of aging (sync-aging) are mysterious and interesting. "Senometabolite" or "senoprotein" are defined as circulating molecules that have causal roles in sync-aging, which requires the establishment of new concepts: age-related fibrotic disorders (A-FiDs), and senometabolite-related disorders (SRDs). Globally, researchers are active in comprehensive and conclusive studies targeting age-related circulating molecules. Recently, the senolytic approach opened a new avenue for aging research. Senolysis, mediated through a genetic/pharmacologic/vaccination approach, reversed aging and pathologies in age-related diseases. Suppression of prosenescent molecules (senocules) and senolysis, the specific depletion of senescent cells, will become next-generation therapies for cardiovascular diseases. |
---|---|
MeSH term(s) | Humans ; Heart Failure/metabolism ; Heart Failure/therapy ; Heart Failure/physiopathology ; Aging/metabolism ; Cellular Senescence ; Animals ; Senotherapeutics/pharmacology ; Senotherapeutics/therapeutic use ; Age Factors |
Chemical Substances | Senotherapeutics |
Language | English |
Publishing date | 2023-07-13 |
Publishing country | Japan |
Document type | Journal Article ; Review |
ZDB-ID | 2068090-9 |
ISSN | 1347-4820 ; 1346-9843 |
ISSN (online) | 1347-4820 |
ISSN | 1346-9843 |
DOI | 10.1253/circj.CJ-23-0419 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ui IV Zs.74: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.